ArticleeLife2022

A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.